CAPRICOR THERAPEUTICS

Company snapshot

Capricor Therapeutics is a publicly traded (NASDAQ: CAPR) biotechnology company with a mission to develop groundbreaking therapies that make a meaningful impact on patients’ lives. Capricor is focused on the development of biologics, primarily cell and exosome-based technologies to treat or prevent a broad range of diseases. Our lead product is a cell therapy designed to treat Duchenne muscular dy

• 8 active pipeline program(s) linked via ClinicalTrials.gov.
• 43 US patent(s) indexed to this assignee profile.
• 8 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for CAPRICOR THERAPEUTICS. Not investment advice.

• Peer + 0 momentum

  Quantum Pharmaceuticals

  TA overlap score 23.6

• Peer + 0 momentum

  Edgewise Therapeutics

  TA overlap score 23

Recent activity

Latest pipeline, patent, and corporate events for CAPRICOR THERAPEUTICS.

1. Jun 8, 2026 Clinical update

   CAP-1002 Allogeneic Cardiosphere-Derived Cells — Phase 2

2. Jun 8, 2026 Clinical update

   Allogeneic Cardiosphere-Derived Cells (CDCs) — Phase 1

3. Jun 8, 2026 Clinical update

   Allogeneic Cardiosphere-Derived Cells (CAP-1002) — Phase 2

4. Jun 5, 2026 Clinical update

   Deramiocel (CAP-1002) — Phase 3

5. Jun 5, 2026 Clinical update

   Deramiocel (CAP-1002) — Phase 2

View all clinical trial activity →

• What is CAPRICOR THERAPEUTICS?

  CAPRICOR THERAPEUTICS is a pharma organization headquartered in San Diego, USA. It trades on NYSE under ticker CAPR. Primary therapeutic focus areas include Duchenne Muscular Dystrophy, Muscular Dystrophies, Covid19, Dilated Cardiomyopathy (DCM), Myocardial Infarction. NovaPharma

• Is CAPRICOR THERAPEUTICS publicly traded?

  Yes. CAPRICOR THERAPEUTICS is listed with ticker CAPR on NYSE per SEC EDGAR records linked on this profile.

• What drugs does CAPRICOR THERAPEUTICS develop or market?

  We link 6 drug profile(s) where CAPRICOR THERAPEUTICS is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/capricor-therapeutics-inc#company-drugs.

• What are the latest developments for CAPRICOR THERAPEUTICS?

  In the last 12 months our linked public records show 8 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does CAPRICOR THERAPEUTICS focus on?

  CAPRICOR THERAPEUTICS focuses on Duchenne Muscular Dystrophy, Muscular Dystrophies, Covid19 based on our analysis of their pipeline programs and drug development activities.